Posts tagged “PPD”
Validic's fast growth; LinkedIn's $1.5B buy; new PPD joint venture; Liquidia demos its tech; Zynga founder returns
In today's Bulldog wrapup of technology and life science news: Startup Validic reports fast growth; LinkedIn's big acquisition; PPD forms a joint venture in Japan; Liquidia demos at vaccine congress; and Zynga's founder returns as CEO.
From our archives: The Fred Eshelman saga includes one-person startup at PPD to Wilmington's Walk of Fame and now a $1.1B sale of Furiex
Looking back at Fred Eshelman's career: A 2009 blog post recapped a tumultuous year for Eshelman and PPD in which the company's stock was hammered and he stepped down as CEO to become executive chairman. But the year was capped with a salute. From there, Eshelman has continued to make headlines.
Clinical research organization Clinipace's fundraising haul today of $9 million puts it in a position to do more of what the Morrisville company has been doing in over the last two years - finding and acquiring companies.
Inside the Bulldog Blog: SAS wins XL Group as Visual Analytics customer; PPD to work with Europeans on allergies; ATTUS expands compliance services; DARA licenses topical gel; Chemring wins big defense contract.
Lowe's, PPD, SAS, Bank of America and Martin Marietta also crack the top 200 in the annual ranking of information technology trend-setters as selected by InformationWeek magazine.
Pozen CEO says there are lessons to be learned from its past partnership deals as the Chapel Hill firm seeks another one.
"We expect growth in the CRO industry to continue accelerating into 2012 and the rise of the strategic partnership model should concentrate these benefits in the hands of a select group of narrow-moat providers," says a Morningstar analyst.
PPD CEO Ray Hill has stepped down from the clinical research organization a week after PPD's acquisition by The Carlyle Group and Hellman & Friedman was finalized. He departs with a $3 million severance package for running the company since September.
Even as shareholders approve the $3.9 billion sale of the contract research organization to private equity groups, the future role of PPD management remains unclear.